Skip to main content

Table 3 Comparison between the two studied groups according to median and IQR of Fibroscan

From: Role of Fibroscan for early detection of hepatocellular carcinoma (HCC) in hepatitis C cirrhotic patients

  Group I (n = 25) Group II (n = 25) T P
Median of Fibroscan
 Min.–Max. 18.0–68.5 14.0–36.0 18.086* < 0.003*
 Mean ± SD 42.08 ± 6.92 25.2 ± 3.0
 Median 40.0 24
IQR of Fibroscan
 Min.–Max. 4.0–16.0 1.80–11.60 16.723* < 0.003*
 Mean ± SD 9.08 ± 0.81 5.21 ± 0.27
 Median 8.0 4.8